Due to the shortage of disposable masks during the COVID-19 pandemic, N95 masks are desperately needed by healthcare personnel. Credit: AptarGroup, Inc.

Global dispensing, drug delivery, and active packaging solutions company AptarGroup has requested the US Food and Drug Administration (FDA) to authorise its mask disinfecting solution.

The company has sought for FDA’s Emergency Use Authorization (EUA) for N95 filtering facepiece respirators (N95 mask) disinfecting solution.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The company claims that its solution easily disinfects N95 masks and will prove beneficial now for frontline health workers due to shortage of masks.

Aptar’s disinfecting solution includes the N95 mask, a small strip of its ActivShield and one-gallon plastic bag. The process can be carried out on-site.

According to the company, the mask can be disinfected by placing it along with ActivShield inside the sealed plastic bag.

The strip then releases Chlorine dioxide to decontaminate the mask, which is ready for use after three hours.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Aptar president and CEO Stephan Tanda said: “Aptar’s technology provides a unique, simple, and effective way to help solve the critical problem of PPE shortages we’re currently facing. 

“We are aiming to provide a solution that is not only fast, but it does not require special equipment or training, making it potentially accessible to the wider healthcare community. 

“This could enable healthcare workers to retain and disinfect their own facemask, helping to maintain continued proper fit to their face.”

As of now, Aptar has submitted the solution’s safety and effectiveness data to the FDA for EUA review and will be made available immediately if approved.

The company is planning to offer approximately four million ActivShield strips a week and is also expanding its production capacity to deliver ten million per week by the end of this month.

Last month, Aptar Food and Beverage unveiled InvisiShield platform, an anti-pathogenic packaging solution.